SUO 2019: Lessons Learned from the eUROGEN Initiative
SUO 2019 eUROGEN referral network, penile cancer, diagnosis and management for rare and complex urogenital conditions, InPACT trial, challenge in rare cancers.
Related Articles
SES AUA 2025: Phase 1 Trial of Mevrometostat (PF-06821497), a Potent and Selective Inhibitor of EZH2, in CRPC
SES AUA 2025 phase 1 trial of mevrometostat (PF-06821497), mevrometostat with enzalutamide plus ADT, abiraterone.
SES AUA 2025: Overall Survival with Darolutamide Versus Placebo in Combination with Androgen Deprivation Therapy and Docetaxel Accounting for Subsequent Therapy: A Sensitivity Analysis from ARASENS
SES AUA 2025, prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), ARASENS trial, Darolutamide, Androgen Deprivation Therapy (ADT), abiraterone, enzalutamide, cabazitaxel.
SES AUA 2025: Validation of PAM50 for Predicting Progression in Active Surveillance: Results from the Miami MAST Prospective Clinical Trial
SES AUA 2025, prostate cancer, Veracyte, Active Surveillance for prostate cancer, SPOP mutations, PTEN mutations, PAM50.
SES AUA 2025: Outcomes of Men with High-Risk Biochemically Recurrent Prostate Cancer who Suspended Enzalutamide Monotherapy Treatment in the Phase 3 EMBARK Study
SES AUA 2025 high-risk biochemically recurrent prostate cancer, enzalutamide monotherapy treatment, phase 3 EMBARK study, EMBARK (NCT02319837).
SES AUA 2025: PSA Dynamics from the Phase 3 EMBARK Trial: A Post Hoc Analysis
SES AUA 2025, prostate cancer, EMBARK trial, Leuprolide, biochemical recurrence in prostate cancer.
Cancer-Related Financial Hardship Among Cancer Survivors: Research from the HINTS-SEER Survey – Apoorv Dhir & Rishi Sekar
Ruchika Talwar interviews Apoorv Dhir and Rishi Sekar about their study on cancer-related financial hardship among cancer survivors. The researchers discuss findings from the HINTS-SEER…
RaLu Trial: Sequence of Radium Then Lutetium in mCRPC Management – Kambiz Rahbar
Oliver Sartor and Kambiz Rahbar discuss the RaLu study examining the safety and efficacy of sequential radiopharmaceutical treatments in metastatic castration-resistant prostate cancer. The discussion…
Pelvic Muscle Rehabilitation after Radical Prostatectomy – Diane Newman
Diane Newman delivers a presentation on pelvic floor muscle rehabilitation following radical prostatectomy, highlighting the prevalence and impact of post-surgical urinary incontinence. She explained that…
SES AUA 2025: Incidence of New Mental Health Diagnoses in Testicular Cancer Survivors
SES AUA 2025 mental health diagnoses in testicular cancer survivors, mental health disorder, orchiectomy for testicular cancer, Truven Marketscan Commercial Claims and Encounters database.
SES AUA 2025: American Urological Association Annual Census Identifies 39% of Practicing Urologists Utilize Unhealthy Coping Mechanisms for Burnout and Stress
SES AUA 2025, urologic workforce shortage, coping mechanisms for urologists, stress management for urologists.